384 related articles for article (PubMed ID: 31021601)
1. Glyoxylic Hydrazone Linkage-Based PEG Hydrogels for Covalent Entrapment and Controlled Delivery of Doxorubicin.
Sharma PK; Singh Y
Biomacromolecules; 2019 Jun; 20(6):2174-2184. PubMed ID: 31021601
[TBL] [Abstract][Full Text] [Related]
2. Hydrazone-Linkage-Based Self-Healing and Injectable Xanthan-Poly(ethylene glycol) Hydrogels for Controlled Drug Release and 3D Cell Culture.
Sharma PK; Taneja S; Singh Y
ACS Appl Mater Interfaces; 2018 Sep; 10(37):30936-30945. PubMed ID: 30148349
[TBL] [Abstract][Full Text] [Related]
3. Highly self-healable and injectable cellulose hydrogels via rapid hydrazone linkage for drug delivery and 3D cell culture.
Jiang X; Yang X; Yang B; Zhang L; Lu A
Carbohydr Polym; 2021 Dec; 273():118547. PubMed ID: 34560959
[TBL] [Abstract][Full Text] [Related]
4. Injectable, Self-Healing, and Biocompatible
Pandit AH; Nisar S; Imtiyaz K; Nadeem M; Mazumdar N; Rizvi MMA; Ahmad S
Biomacromolecules; 2021 Sep; 22(9):3731-3745. PubMed ID: 34436877
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation of Thermo-responsive Gel in pH-sensitive Polymersomes as Dual-Responsive Smart carriers for Controlled Release of Doxorubicin.
Oroojalian F; Babaei M; Taghdisi SM; Abnous K; Ramezani M; Alibolandi M
J Control Release; 2018 Oct; 288():45-61. PubMed ID: 30171978
[TBL] [Abstract][Full Text] [Related]
6. pH-responsive self-healing injectable hydrogel based on N-carboxyethyl chitosan for hepatocellular carcinoma therapy.
Qu J; Zhao X; Ma PX; Guo B
Acta Biomater; 2017 Aug; 58():168-180. PubMed ID: 28583902
[TBL] [Abstract][Full Text] [Related]
7. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(29):5757-66. PubMed ID: 19643472
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin-polyphosphazene conjugate hydrogels for locally controlled delivery of cancer therapeutics.
Chun C; Lee SM; Kim CW; Hong KY; Kim SY; Yang HK; Song SC
Biomaterials; 2009 Sep; 30(27):4752-62. PubMed ID: 19520429
[TBL] [Abstract][Full Text] [Related]
9. Localized controlled release of bevacizumab and doxorubicin by thermo-sensitive hydrogel for normalization of tumor vasculature and to enhance the efficacy of chemotherapy.
Darge HF; Andrgie AT; Hanurry EY; Birhan YS; Mekonnen TW; Chou HY; Hsu WH; Lai JY; Lin SY; Tsai HC
Int J Pharm; 2019 Dec; 572():118799. PubMed ID: 31678386
[TBL] [Abstract][Full Text] [Related]
10. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells.
Dong DW; Xiang B; Gao W; Yang ZZ; Li JQ; Qi XR
Biomaterials; 2013 Jul; 34(20):4849-59. PubMed ID: 23541420
[TBL] [Abstract][Full Text] [Related]
11. An injectable and biodegradable hydrogel based on poly(α,β-aspartic acid) derivatives for localized drug delivery.
Lu C; Wang X; Wu G; Wang J; Wang Y; Gao H; Ma J
J Biomed Mater Res A; 2014 Mar; 102(3):628-38. PubMed ID: 23554110
[TBL] [Abstract][Full Text] [Related]
12. Supramolecular hydrogels based on poly (ethylene glycol)-poly (lactic acid) block copolymer micelles and α-cyclodextrin for potential injectable drug delivery system.
Poudel AJ; He F; Huang L; Xiao L; Yang G
Carbohydr Polym; 2018 Aug; 194():69-79. PubMed ID: 29801860
[TBL] [Abstract][Full Text] [Related]
13. In situ chemically crosslinked injectable hydrogels for the subcutaneous delivery of trastuzumab to treat breast cancer.
Lo YW; Sheu MT; Chiang WH; Chiu YL; Tu CM; Wang WY; Wu MH; Wang YC; Lu M; Ho HO
Acta Biomater; 2019 Mar; 86():280-290. PubMed ID: 30616077
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release.
Ruan S; Cao X; Cun X; Hu G; Zhou Y; Zhang Y; Lu L; He Q; Gao H
Biomaterials; 2015 Aug; 60():100-10. PubMed ID: 25988725
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone-loaded, injectable pullulan-poly(ethylene glycol) hydrogels for bone tissue regeneration in chronic inflammatory conditions.
Chauhan N; Gupta P; Arora L; Pal D; Singh Y
Mater Sci Eng C Mater Biol Appl; 2021 Nov; 130():112463. PubMed ID: 34702538
[TBL] [Abstract][Full Text] [Related]
16. Legumain-cleavable 4-arm poly(ethylene glycol)-doxorubicin conjugate for tumor specific delivery and release.
Zhou H; Sun H; Lv S; Zhang D; Zhang X; Tang Z; Chen X
Acta Biomater; 2017 May; 54():227-238. PubMed ID: 28315495
[TBL] [Abstract][Full Text] [Related]
17. Coordinate bonding strategy for molecularly imprinted hydrogels: toward pH-responsive doxorubicin delivery.
Zhang Q; Zhang L; Wang P; Du S
J Pharm Sci; 2014 Feb; 103(2):643-51. PubMed ID: 24395706
[TBL] [Abstract][Full Text] [Related]
18. An injectable hydrogel with pH-sensitive and self-healing properties based on 4armPEGDA and N-carboxyethyl chitosan for local treatment of hepatocellular carcinoma.
Zhan J; Wu Y; Wang H; Liu J; Ma Q; Xiao K; Li Z; Li J; Luo F; Tan H
Int J Biol Macromol; 2020 Nov; 163():1208-1222. PubMed ID: 32645496
[TBL] [Abstract][Full Text] [Related]
19. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
[TBL] [Abstract][Full Text] [Related]
20. Liposomal doxorubicin loaded PLGA-PEG-PLGA based thermogel for sustained local drug delivery for the treatment of breast cancer.
Cao D; Zhang X; Akabar MD; Luo Y; Wu H; Ke X; Ci T
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):181-191. PubMed ID: 30686051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
